Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by TechTargeton Oct 06, 2015 10:31am

56 Views

Post# 24167040

RE:Share price and revenue stream 2.0 reloaded!

Thanks Bazooka73, so your calculations are that the share price in 2015 should be $1.39 per share while SBM is trading at 0.165 cents currently. So an easy, honest 8x bagger!

How rare is that on penny stocks that always generally trade well above value!?

I really like the facts they have a parterned deal with Valeant and Fosun! Big projects.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading